TFFP TFF Pharmaceuticals
- 1.6800
- +0.0500+3.07%
- 1.7700
- +0.0900+5.36%
TFF Pharmaceuticals News
12 Health Care Stocks Moving In Friday's Pre-Market Session
TFF Pharmaceuticals (TFFP) Upgraded to Strong Buy: Here's Why
Top Premarket Decliners
TFF Pharmaceuticals Shares Are Trading Higher After the Company Announces Preclinical Data Published in the Journal of Drug Delivery Science and Technology.
TFF Pharmaceuticals' Technology Generates Superior Inhalational Dry Powder Formulations for Pulmonary Drug Delivery
TFF Pharmaceuticals Enters Pact for Dry Powder MRNA-based Covid Treatment
TFF Pharmaceuticals Announced Its New Partnership With Emory University And The Biomedical Advanced Research And Development Authority To Develop A Dry Powder Inhaled Mrna-based Treatment For Influenza And Covid
TFF Pharmaceuticals Announces Positive Preclinical Data From Bivalent Universal Influenza Vaccine Candidates Manufactured by TFF Following Intranasal Immunization
TFF Pharmaceuticals to Present at the H.C. Wainwright 26th Annual Global Investment Conference
TFF Pharmaceuticals Second Quarter 2024 Earnings: Beats Expectations
TFF Pharmaceuticals GAAP EPS of -$1.22 Misses by $0.41, Revenue of $0.65M Beats by $0.5M
TFF Pharmaceuticals, Inc. (TFFP) Reports Q2 Loss, Tops Revenue Estimates
Earnings Flash (TFFP) TFF PHARMACEUTICALS Posts Q2 Loss $-1.22
TFF Pharmaceuticals | 10-Q: Q2 2024 Earnings Report
Express News | TFF Pharmaceuticals Q2 Net Income USD -4.5 Million
Express News | TFF Pharmaceuticals Q2 Basic EPS USD -1.22
Express News | TFF Pharmaceuticals Reports Second Quarter Financial Results and Provides Corporate Update
TFF Pharmaceuticals Shares Update on Recent Developments
Express News | TFF Pharmaceuticals: Observed 6.5-Fold Reduction in Number of Abnormally Expressed Rejection-Related Gene Sets After Treatment With TFF Tac
Express News | TFF Pharmaceuticals: No Production of Donor-Specific Antibodies (Dsa) After Treatment With TFF Tac
Analysis
Price Target
No Data
No Data